Related content

Opening Pandora’s box in the UK: a hypothetical pharmacogenetic test for clozapine

By Spencer Benjamin WJ   Prainsack Barbara   Rujescu Dan   Giegling Ina   Collier David A   Gaughran Fiona   MacCabe James H   Barr Cathy L   Sigurdsson Engilbert   Stovring Henrik   Malhotra Anil K   Curran Sarah R  

Pharmacogenomics, Vol. 14, Iss. 15, 2013-11 ,pp. : 1907-1914

Future Medicine

Access to resources Recommend Favorite

US FDA advises of risk factor for PML, gives go ahead for test

By  

Reactions Weekly, Vol. 1, Iss. 1386, 2012-01 ,pp. : 2-2

Adis International

Access to resources Recommend Favorite

Evaluation of a Pharmacogenetic Test in Thailand for Abacavir Hypersensitivity Screening in Human Immunodeficiency Virus Infection

By  

Current Pharmacogenomics and Personalized Medicine (Formerly Current Pharmacogenomics), Vol. 11, Iss. 3, 2013-09 ,pp. : 231-236

Bentham Science Publishers

Access to resources Recommend Favorite

Likelihood Ratio Test-Based Method for Signal Detection in Drug Classes Using FDA's AERS Database

By Huang Lan   Zalkikar Jyoti   Tiwari Ram C.  

Journal of Biopharmaceutical Statistics, Vol. 23, Iss. 1, 2013-01 ,pp. : 178-200

Taylor & Francis Ltd

Access to resources Recommend Favorite

Clopidogrel + eptifibatide CLEARs PLATELETS after coronary stenting

By  

Inpharma, Vol. 1, Iss. 1480-1481, 2005-01 ,pp. : 16-16

Adis International

Access to resources Recommend Favorite